AGC Biologics, your friendly CDMO expert, is the 2026 recipient of the Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance. The award recognizes the company's exemplary ...

The use of biologics is rapidly increasing as new drugs are approved for label expansions. Monoclonal antibodies, multispecific antibodies, and antibody-drug conjugates (ADCs) are being implemented in ...

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturing facilities in Wuxi - Drug Substance ...

Although biologics can be effective in reducing allergy symptoms, the high cost of these medications must be weighed when determining whether to use them for allergic rhinitis. But these typical ...

Pregnant women who take biologic medication for rheumatoid arthritis are not running the risk of their infant developing serious/opportunistic infections, according to research presented at the 2017 ...

The market offers growth opportunities driven by increased demand for personalized medicine, advancements in cell and gene ...

Biologic drugs are a newer treatment option for chronic rhinosinusitis with nasal polyps. They work differently from other treatments. Nasal polyps are small, noncancerous growths that develop in the ...

Sino Biological US, Inc., a global leader in recombinant proteins, antibodies, and CRO services, will be featured on Inside Business Today, hosted by Bill Rancic and Giuliana Rancic. The segment, ...

Two of the U.S. premarket regulatory requirements for infant formula involve specific “quality factors”: the biological quality of protein in the infant formula and the ability of the infant formula ...

The National Academies will convene a Committee to conduct a study to examine and report on the state of the science regarding methodologies for assessing biological quality of protein in an infant ...